Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells

scientific article (publication date: 24 March 1999)

Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1006/BBRC.1999.0291
P3181OpenCitations bibliographic resource ID4416225
P698PubMed publication ID10080935
P5875ResearchGate publication ID223666827

P50authorAlan W StittQ63865513
P2093author name stringHe C
Vlassara H
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectendotheliumQ111140
P304page(s)549-556
P577publication date1999-03-01
P1433published inBiochemical and Biophysical Research CommunicationsQ864228
P1476titleCharacterization of the advanced glycation end-product receptor complex in human vascular endothelial cells
P478volume256

Reverse relations

cites work (P2860)
Q33727690AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease
Q35067948Advanced glycation endproducts and osteoarthritis
Q28365776Advanced glycation: an important pathological event in diabetic and age related ocular disease
Q73980634Age-related changes in cells and tissues due to advanced glycation end products (AGEs)
Q28362386Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells
Q40558928Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products
Q48580864Bowman Lecture 1998. Diabetic retinopathy: some cellular, molecular and therapeutic considerations
Q44650505Cellular Carbonyl Stress Enhances the Expression of Plasminogen Activator Inhibitor-1 in Rat White Adipocytes via Reactive Oxygen Species-dependent Pathway
Q37089750Cellular signaling and potential new treatment targets in diabetic retinopathy
Q40477757Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epithelium
Q90720617Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products
Q35087841Diabetic complications and dysregulated innate immunity
Q37733102Dietary hyperglycemia, glycemic index and metabolic retinal diseases
Q45151232Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products
Q35168430Endothelins in chronic diabetic complications.
Q90073141Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases
Q35842591Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes
Q38258947Galectin-3: an emerging all-out player in metabolic disorders and their complications
Q53510307Glycated serum albumin stimulates expression of endothelial cell specific molecule-1 in human umbilical vein endothelial cells: Implication in diabetes mediated endothelial dysfunction.
Q39700115Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction.
Q33186938Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products
Q73040201Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins
Q38330759Mechanisms of distal axonal degeneration in peripheral neuropathies.
Q41997847Neurodegenerative diseases of the retina and potential for protection and recovery
Q34103169Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy
Q34470639The AGE-receptor in the pathogenesis of diabetic complications
Q30317876The effect of an AGE-rich dietary extract on the activation of NF-κB depends on the cell model used.
Q24602544The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas
Q34436018The maillard reaction in eye diseases
Q35166467The role of advanced glycation in the pathogenesis of diabetic retinopathy.
Q34090982Therapeutic potential of endothelin receptor antagonists in diabetes
Q35553234Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3.
Q36245387Understanding RAGE, the receptor for advanced glycation end products
Q28081090Vascular Effects of Dietary Advanced Glycation End Products
Q37636453Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms
Q37202605Zerumbone, a Phytochemical of Subtropical Ginger, Protects against Hyperglycemia-Induced Retinal Damage in Experimental Diabetic Rats
Q81393241[Maillard reaction products in food as pro-inflammatory and pro-arteriosclerotic factors of degenerative diseases]

Search more.